Cargando…
Association of thalamic hyperactivity with treatment-resistant depression and poor response in early treatment for major depression: a resting-state fMRI study using fractional amplitude of low-frequency fluctuations
Despite novel antidepressant development, 10–30% of patients with major depressive disorder (MDD) have antidepressant treatment-resistant depression (TRD). Although new therapies are needed, lack of knowledge regarding the neural mechanisms underlying TRD hinders development of new therapeutic optio...
Autores principales: | Yamamura, T, Okamoto, Y, Okada, G, Takaishi, Y, Takamura, M, Mantani, A, Kurata, A, Otagaki, Y, Yamashita, H, Yamawaki, S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872444/ https://www.ncbi.nlm.nih.gov/pubmed/26954981 http://dx.doi.org/10.1038/tp.2016.18 |
Ejemplares similares
-
Alterations in amplitude of low frequency fluctuation in treatment‐naïve major depressive disorder measured with resting‐state fMRI
por: Liu, Jie, et al.
Publicado: (2014) -
Enhancing Multi-Center Generalization of Machine Learning-Based Depression Diagnosis From Resting-State fMRI
por: Nakano, Takashi, et al.
Publicado: (2020) -
Amplitude of low-frequency fluctuations on Alzheimer’s disease with depression: evidence from resting-state fMRI
por: Mu, Yuzhu, et al.
Publicado: (2020) -
A comparative study of amplitude of low-frequence fluctuation of resting-state fMRI between the younger and older treatment-resistant depression in adults
por: Sun, Jifei, et al.
Publicado: (2022) -
Kynurenic acid is a potential overlapped biomarker between diagnosis and treatment response for depression from metabolome analysis
por: Erabi, Hisayuki, et al.
Publicado: (2020)